TITLE

Stem Cell Ruling Won't Harm Programs, Biotech Predicts

AUTHOR(S)
Hirsh, Lou
PUB. DATE
September 2010
SOURCE
San Diego Business Journal;9/6/2010, Vol. 31 Issue 36, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article announces that the recent court action federal funding of embryonic stem cell research of the International Stem Cell Corp. (ISCO) won't negatively impact the business's therapeutic programs tied to human stem cells.
ACCESSION #
53885172

 

Related Articles

  • International Stem Cell Gets Parthenogenetic Patent. Chambers, Heather // San Diego Business Journal;6/14/2010, Vol. 31 Issue 24, p6 

    The article reports on the potential of the International Stem Cell Corp. in Oceanside, California, to receive a patent related to the development of human parthenogenetic stem cells.

  • Biotech Firm Establishing An Operation in India. Hirsch, Lou // San Diego Business Journal;7/26/2010, Vol. 31 Issue 30, p9 

    The article reports on the establishment of an affiliate company by International Stem Cell Corp. which will be used for the manufacture of pharmaceutical products in San Diego, California.

  • Biotech Takes Steps to Form European Subsidiary. Hirsh, Lou // San Diego Business Journal;8/2/2010, Vol. 31 Issue 31, p6 

    The article reports on Oceanside, California-based International Stem Cell Corp.'s preliminary financial arrangements to create a European subsidiary to be called ISCO Europe.

  • Cell Research Company Reports Higher Revenue. Hirsh, Lou // San Diego Business Journal;6/6/2011, Vol. 32 Issue 23, p27 

    The article reports on the financial performance of International Stem Cell Corp. wherein its revenue is 1.5 million dollars for the first quarter of 2011.

  • Reminder: Intl Stem Cell Holding Business Update Conference Call on Aug 10.  // Biomedical Market Newsletter;8/12/2011, Vol. 21, p720 

    The article offers information on the business updates conference call and webcast of International Stem Cell Corp. to be held on August 10, 2011.

  • International Stem Cell Corp (ISCO) Announces That Donna Queen, Former President/CEO of ZO SKIN HEALTH, the Luxury Brand Created by Zein Obagi, MD, Has Joined ISCO Executive Team.  // Biomedical Market Newsletter;6/19/2011, p345 

    The article announces that Donna Queen, former President/Chief Executive Officer (CEO) of ZO Skin Health®, has joined the International Stem Cell Corp. (ISCO) wherein she will manage the Lifeline Skin Care's subsidiary of the company.

  • Untitled.  // Biomedical Market Newsletter;4/7/2011, p211 

    A correction to the article "Kenneth Aldrich, Executive Chairman of International Stem Cell Corp, Will Make a Public Appearance March 16 2011 on Behalf of ISCO," is presented.

  • At-the-Market Financing Facility Secures ISCO $25M.  // Bioworld Week;12/20/2010, Vol. 18 Issue 51, p3 

    The article reports that Apsire Capital Fund LLC agreed to purchase 333,333 shares from International Stem Cell Corp. (ISCO) and is granted a financing facility which allows Aspire to purchase up to 25 million dollars in equity capital over the next three years at ISCO's discretion.

  • Local Biotech Execs Fly to New York City to Make Some News. Chambers, Heather // San Diego Business Journal;9/10/2007, Vol. 28 Issue 37, p16 

    The article offers biotechnology-related news briefs in California. Many local biotechnology executives in San Diego city have attended the 14th anniversary of Newsmakers in the Biotech Industry held in New York City. Keith Wilson has been named president and chief scientific officer (CSO) of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics